ACCELERON PHARMA INC Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for July 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 48,751 | |
| Jul 30 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 40,000 | 35 K to 40 K (+14.29 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 800 | 4,064 | 21,496 | |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 4,000 | |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.22 | 200 | 6,644 | 11,500 | 11.7 K to 11.5 K (-1.71 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.31 | 1,000 | 32,310 | 11,700 | 12.7 K to 11.7 K (-7.87 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.22 | 800 | 26,576 | 32,004 | 32.8 K to 32 K (-2.44 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 800 | 4,064 | 32,804 | 32 K to 32.8 K (+2.50 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.74 | 100 | 3,274 | 32,004 | 32.1 K to 32 K (-0.31 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.29 | 3,900 | 125,931 | 32,104 | 36 K to 32.1 K (-10.83 %) |
| Jul 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 36,004 | 32 K to 36 K (+12.50 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 1,193 | 6,299 | 36,307 | |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 807 | 3,131 | 23,693 | |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.38 | 2,000 | 62,760 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 1,193 | 6,299 | 59,656 | 58.5 K to 59.7 K (+2.04 %) |
| Jul 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 807 | 3,131 | 58,463 | 57.7 K to 58.5 K (+1.40 %) |
| Jul 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 5,500 | 32,340 | 4,461 | |
| Jul 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 30.00 | 5,500 | 165,000 | 22,701 | 28.2 K to 22.7 K (-19.50 %) |
| Jul 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 5,500 | 32,340 | 28,201 | 22.7 K to 28.2 K (+24.23 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 53,751 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 55,751 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.39 | 95 | 2,887 | 35,000 | 35.1 K to 35 K (-0.27 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.68 | 1,905 | 56,540 | 35,095 | 37 K to 35.1 K (-5.15 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 2,000 | 7,760 | 37,000 | 35 K to 37 K (+5.71 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.27 | 377 | 11,412 | 35,000 | 35.4 K to 35 K (-1.07 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.65 | 4,623 | 137,072 | 35,377 | 40 K to 35.4 K (-11.56 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 40,000 | 35 K to 40 K (+14.29 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 3,367 | 17,104 | 259,133 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 15,633 | 60,656 | 27,867 | |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 30.25 | 1,400 | 42,350 | 17,584 | 19 K to 17.6 K (-7.37 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.66 | 17,600 | 522,016 | 18,984 | 36.6 K to 19 K (-48.11 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 3,367 | 17,104 | 36,584 | 33.2 K to 36.6 K (+10.14 %) |
| Jul 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 15,633 | 60,656 | 33,217 | 17.6 K to 33.2 K (+88.90 %) |